triple negative breast cancer

https://tnbcfoundation.org/ Home | Triple Negative Breast Cancer Foundation A credible source for triple negative breast cancer information, helpful resources and a caring community for TNBC patients and their families. triple negative breast cancer foundation https://www.michigan.gov/whitmer/news/proclamations/2023/03/01/march-2023-triple-negative-breast-cancer-awareness-month March 2023: Triple Negative Breast Cancer Awareness Month triple negative breast cancer march awareness month https://www.aramis.admin.ch/Beteiligte/?ProjectID=47790&Sprache=fr-CH Small molecule FZD7 inhibitors for Triple Negative Breast Cancer - Participants Small molecule FZD7 inhibitors for Triple Negative Breast Cancer triple negative breast cancer small molecule inhibitors participants https://www.techtransfer.nih.gov/patent/e-041-2018-0-ep-01 A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER | Technology Transfer triple negative breast cancer method treating technology transfer https://cancercenter.gwu.edu/news/new-study-finds-nanoparticles-show-promise-therapy-triple-negative-breast-cancer New Study Finds Nanoparticles Show Promise in Therapy for Triple-Negative Breast Cancer | GW Cancer... Adam Friedman, MD, is the senior author of a study on the efficacy of nanoparticles in therapies for triple-negative breast cancer. triple negative breast cancer https://cancerchat.cancerresearchuk.org/f/newly-diagnosed/94638/triple-negative-breast-cancer/519856 Triple negative breast cancer - Newly diagnosed - Cancer Chat | Cancer Research UK Hi if been diagnosed with stage 1 triple negative breast cancer they told me I would need 6 chemotherapy and a week off radiotherapy now iv getting results of... triple negative breast cancer newly diagnosed chat research uk https://pubmed.ncbi.nlm.nih.gov/24961674/ The prevalence of BRCA1/2 mutations of triple-negative breast cancer patients in Xinjiang multiple... These results suggest that premenopausal women with triple-negative breast cancer may be candidates for genetic testing for BRCA1/2 in the Xinjiang region of... triple negative breast cancer https://pubmed.ncbi.nlm.nih.gov/36096335/ Neoadjuvant immunotherapy in triple-negative breast cancer: lesson learnt, remaining questions Neoadjuvant immunotherapy in triple-negative breast cancer: lesson learnt, remaining questions triple negative breast cancer lesson learnt immunotherapy https://pubmed.ncbi.nlm.nih.gov/32605126/ Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives Triple-negative breast cancer (TNBC) is a heterogeneous group of tumors characterized by aggressive behavior, high risk of distant recurrence, and poor... triple negative breast cancer state of the art https://cordis.europa.eu/project/id/893597/results Tumor compartment-specific effects of P70S6K in early triple negative breast cancer: regulation of... Deliverables, publications, datasets, software, exploitable results triple negative breast cancer https://pmc.ncbi.nlm.nih.gov/articles/PMC11588072/ Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor... Transcriptomic plasticity of TNBC promotes metastatic growth and renders these cancers resistant to targeted therapies. Inhibition of CDK8/19 Mediator kinases,... triple negative breast cancer kinase inhibitors https://digital.library.adelaide.edu.au/items/bc5d0803-d2ac-49a1-8989-f88a417c44bf Improved Control of Triple-Negative Breast Cancer Tumor and Metastasis with a pH-Sensitive... Polymer based nanoformulations offer substantial prospects for efficacious chemotherapy delivery. Here, we developed a pH-responsive polymeric nanoparticle... triple negative breast cancer https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-comparing-different-chemotherapy-drugs-for-advanced-triple-negative-breast-cancer A trial comparing different chemotherapy drugs for advanced triple negative breast cancer (TNT... This trial is looking at 2 different chemotherapy drugs for breast cancer that doesn't have receptors for oestrogen, progesterone or HER2. triple negative breast cancer https://digitalcommons.wustl.edu/oa_4/5177/ "Targeting triple-negative breast cancer with momordicine-I for therape" by Kousik Kesh, Ellen T... By Kousik Kesh, Ellen T Tran, Ruchi A Patel, et al., Published on 07/15/25 triple negative breast cancer https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1230911/full Frontiers | Oxidative stress genes define two subtypes of triple-negative breast cancer with... Background Although oxidative stress-related genes have been confirmed to be closely related to the prognosis of triple-negative breast cancer patients, ther... triple negative breast cancer https://ec2-3-220-198-172.compute-1.amazonaws.com/1078-0432-ccr-21-2272-trilaciclib-breast-cancer/ Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final... Nov 17, 2023 - Gail Lynn Shaw Wright, MD, FACP, FCCP is co-author of this study that examines the efficacy of administering Trilaciclib prior to chemotherapy in patients with... triple negative breast cancer https://tnbcstudy.com/ A Clinical Research Study for Triple Negative Breast Cancer (TNBC) Now enrolling at select sites in the United States! Learn more about an investigational imaging (CLR 131) and treatment (CLR 125) study for advanced or... triple negative breast cancer clinical research study tnbc https://pubmed.ncbi.nlm.nih.gov/31215169/ LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by... Emerging evidence has suggested that long noncoding RNAs (lncRNA) involved in the development and progression of cancer. Triple negative breast cancer (TNBC)... triple negative breast cancer https://pmc.ncbi.nlm.nih.gov/articles/PMC7646583/ Triple-negative breast cancer therapy: Current and future perspectives (Review) - PMC Triple-negative breast cancer (TNBC) accounts for 10-15% of all breast cancer cases. TNBCs lack estrogen and progesterone receptors and express low levels of... triple negative breast cancer current and future therapy https://collaborate.princeton.edu/en/publications/protein-tyrosine-phosphatase-ubash3b-is-overexpressed-in-triple-n/ Protein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes... triple negative breast cancer protein tyrosine phosphatase https://www.frontiersin.org/research-topics/33012/targeting-triple-negative-breast-cancer-by-natural-compounds/magazine Targeting Triple Negative Breast Cancer by Natural Compounds | Frontiers Research Topic Breast cancer is the most common cancer in women worldwide and remains an important global health issue after lung cancer. Breast cancer is a heterogeneous... triple negative breast cancer natural compounds targeting https://tnbc.tigerlilyfoundation.org/ Triple Negative Breast Cancer (TNBC) | Tigerlily Foundation – If a breast cancer is ER-negative,... triple negative breast cancer tigerlily foundation https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-looking-at-olaparib-azd6738-and-azd1775-for-triple-negative-breast-cancer-violette A study looking at olaparib, AZD6738 and AZD1775 for triple negative breast cancer (VIOLETTE) This study is comparing olaparib on its own and in combination with AZD6738 for triple negative breast cancer that has spread. triple negative breast cancer https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.656687/full Frontiers | Lovastatin Inhibits EMT and Metastasis of Triple-Negative Breast Cancer Stem Cells... Triple-negative breast cancer (TNBC) is more aggressive and has poorer prognosis compared to other subtypes of breast cancer. Epithelial-to-mesenchymal trans... triple negative breast cancer https://www.techtransfer.nih.gov/patent/e-041-2018-0-ep-03 A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER | Technology Transfer triple negative breast cancer method treating technology transfer https://cancerchat.cancerresearchuk.org/f/newly-diagnosed/94638/triple-negative-breast-cancer/519865 Triple negative breast cancer - Newly diagnosed - Cancer Chat | Cancer Research UK Hi if been diagnosed with stage 1 triple negative breast cancer they told me I would need 6 chemotherapy and a week off radiotherapy now iv getting results of... triple negative breast cancer newly diagnosed chat research uk https://nrc-publications.canada.ca/eng/view/object/?id=85a450a2-78c1-4251-a493-c3e7666dba1e Nanoparticle-mediated mRNA delivery to triple-negative breast cancer (TNBC) patient-derived... Nanoparticle-mediated mRNA delivery to triple-negative breast cancer (TNBC) patient-derived xenograft (PDX) tumors triple negative breast cancer mrna delivery https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1018786/full Frontiers | CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil Triple-negative breast cancer (TNBC) is known as the most intricate and hard-to-treat subtype of breast cancer. TNBC cells do not express the well-known estr... car t cell therapy triple negative breast cancer https://www.techtransfer.nih.gov/patent/e-041-2018-0-us-01 A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER | Technology Transfer triple negative breast cancer method treating technology transfer https://accio.github.io/biology/2020/05/26/LOX-drug-resistance.html LOX mediates doxorubicin resistance in triple-negative breast cancer models | David Discovers Drug... May 26, 2020 - Saatci et al. report on Nature Communication that targeting lysyl oxidase (LOX) overcomes drug resistance in cellular and mouse models of triple-negative... triple negative breast cancer https://adisinsight.springer.com/trials/700381954?error=cookies_not_supported&code=208a44fa-430a-4622-aff9-57a4be781c5c Efficacy and Safety of Viscum Album in Patients With Triple-negative Breast Cancer Undergoing... The goal of this clinical trial is to evaluate the efficacy and safety of Viscum album extract when used in combination with pembrolizumab as adjuvant triple negative breast cancer efficacy and safety https://pubmed.ncbi.nlm.nih.gov/36542180/ Mathematical Model of Triple-Negative Breast Cancer in Response to Combination Chemotherapies Triple-negative breast cancer (TNBC) is a heterogenous disease that is defined by its lack of targetable receptors, thus limiting treatment options and... triple negative breast cancer mathematical model https://www.sciencedaily.com/releases/2011/02/110228151915.htm New peptide could be effective treatment for triple negative breast cancer | ScienceDaily A new leptin receptor antagonist peptide has demonstrated efficacy against triple negative breast cancer. triple negative breast cancer could be effective treatment https://www.researchandmarkets.com/reports/5731338/triple-negative-breast-cancer-drugs-global Triple Negative Breast Cancer Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by... Triple Negative Breast Cancer Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type triple negative breast cancer https://pubmed.ncbi.nlm.nih.gov/34238140/ Epigenetics of Triple-Negative Breast Cancer via Natural Compounds Triple-negative breast cancer (TNBC) is a highly resistant, lethal, and metastatic sub-division of breast carcinoma, characterized by the deficiency of... triple negative breast cancer via natural epigenetics compounds https://kkumar.exblog.jp/244585112/ DelveInsight Coverage of the Triple Negative Breast Cancer Market : Stay Ahead in Pharma with... Triple-negative breast cancer (TNBC) persists as one of oncology's most formi... triple negative breast cancer https://www.news-medical.net/news/20211116/New-metabolic-vulnerabilities-of-subsets-of-triple-negative-breast-cancer-discovered.aspx New metabolic vulnerabilities of subsets of triple-negative breast cancer discovered Nov 16, 2021 - Researchers have identified a metabolic enzyme and pathway in some triple-negative breast cancer (TNBC) patients, which they hope could serve as a biomarker to... triple negative breast cancer new metabolic vulnerabilities subsets https://cancer.osu.edu/news/triple-negative-breast-cancer-subtypes-identified-using-microrna Triple-Negative Breast Cancer Subtypes Identified Using microRNA Dr. Pierluigi Gasparini Triple-negative breast cancer is an aggressive form of breast cancer that has few treatment options; This large-scale study shows triple negative breast cancer subtypes identified using microrna https://data.mendeley.com/datasets/t3hrxcbx5g/1 TAF7 Directly Targets SAA1 to Enhance Triple-Negative Breast Cancer Metastasis via Phosphorylating... we analyzed the transcriptome profiles of 13020 cells from the TNBC sample. Our data unveiled an aggressive group of epithelial cells, potentially metastatic... triple negative breast cancer https://cancercenter.gwu.edu/news/hdac6-can-control-tumor-growth-and-halt-metastasis-triple-negative-breast-cancer HDAC6 Can Control Tumor Growth and Halt Metastasis in Triple-Negative Breast Cancer | GW Cancer... Genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer in vivo, according to a new study published in... triple negative breast cancer https://data.mendeley.com/datasets/jcmyx924yy/1 Research Data: The 2-Dimensional Structure Prediction of Triple-Negative Breast Cancer (TNBC)... This data is the computation result of miR-145, LINC-ROR, and mRNA ARF6 sequence with Vienna RNA Package and miRTAR-BASE. triple negative breast cancer https://medicalgiving.stanford.edu/why-giving-matters/supporting-research-in-triple-negative-breast-cancer.html A Brother's Gift: Supporting Research in Triple Negative Breast Cancer | Medical Center Development... Rakesh Marwah, MD, undertook a limit-defying journey to give back and rally others on behalf of his sister Shelley Marwah, a cancer survivor, and Melinda... triple negative breast cancer https://open.clemson.edu/all_dissertations/2010/ "Triple Negative Breast Cancer: Incidence Rates; Phenotype, Demographic" by Annamalar P. Jeyasehar A breast tumor with a histology report that lacks Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Receptor 2/neu is identified as a Triple... triple negative breast cancer incidence rates https://www.sciencedaily.com/releases/2022/10/221017102356.htm New drug target for triple-negative breast cancer | ScienceDaily Research reports a combination of a novel small inhibitory molecule and an FDA-approved chemotherapy drug suppresses the growth of triple-negative breast... triple negative breast cancer new drug target sciencedaily https://pubmed.ncbi.nlm.nih.gov/28254410/ Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by... Triple negative breast cancer (TNBC) typically exhibits rapid progression, high mortality and faster relapse rates relative to other breast cancer subtypes. In... triple negative breast cancer https://pubmed.ncbi.nlm.nih.gov/40590219/ Targeting MTAP increases PARP inhibitor susceptibility in triple-negative breast cancer through a... Triple-negative breast cancer (TNBC) represents the most malignant subtype of breast cancer. The clinical application of PARP inhibitors (PARPi) is limited by... triple negative breast cancer https://cancerchat.cancerresearchuk.org/f/newly-diagnosed/94638/triple-negative-breast-cancer Triple negative breast cancer - Newly diagnosed - Cancer Chat | Cancer Research UK Hi if been diagnosed with stage 1 triple negative breast cancer they told me I would need 6 chemotherapy and a week off radiotherapy now iv getting results of... triple negative breast cancer newly diagnosed chat research uk https://www.justgiving.com/campaign/tnbcday2026 Fundraise for Triple Negative Breast Cancer Day - March 3rd, 2026 - JustGiving Triple Negative Breast Cancer Day is the only global event dedicated to raising both awareness and funds exclusively for triple negative breast cancer. 100% of... triple negative breast cancer fundraise https://kuscholarworks.ku.edu/entities/publication/1169b1f6-de6a-4fca-b7cc-47634e9551e7 Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking... Triple negative breast cancers are an aggressive subtype of breast cancer, characterized by the lack of estrogen receptor, progesterone receptor and Her2... triple negative breast cancer https://researchdata.gla.ac.uk/1229/ Triple negative breast cancer cohort - Enlighten Research Data triple negative breast cancer cohort enlighten research data https://scholars.cityu.edu.hk/en/studentTheses/regulation-and-mechanistic-functions-of-anln-in-triple-negative-b/ Regulation and Mechanistic Functions of ANLN in Triple-negative Breast Cancer - CityUHK Scholars triple negative breast cancer https://www.mdpi.com/1420-3049/28/9/3662 A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy Paclitaxel-triethylenetetramine hexaacetic acid conjugate (PTX-TTHA), a novel semi-synthetic taxane, is designed to improve the water solubility and cosolvent... triple negative breast cancer novel paclitaxel derivative chemotherapy https://pubmed.ncbi.nlm.nih.gov/30186165/ Association Between BRCA Status and Triple-Negative Breast Cancer: A Meta-Analysis Triple-negative breast cancer (TNBC) is a subtype of aggressive breast cancer and characterized by a lack of the expression of estrogen receptor, progesterone... triple negative breast cancer https://www.researchandmarkets.com/reports/5524186/triple-negative-breast-cancer-tnbc-market Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032 Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032 triple negative breast cancer market insight tnbc https://connect.mayoclinic.org/discussion/just-diagnosed-with-trip-negative-breast-cancer/ Just diagnosed with triple negative breast cancer | Mayo Clinic Connect Good day everyone, I was just diagnosed with triple negative breast cancer (we believe it is in the first stage due to normal CBC) and... triple negative breast cancer just diagnosed mayo clinic connect https://pubchem.ncbi.nlm.nih.gov/patent/US-10918734-B2 Treatment of high Trop-2 expressing triple negative breast cancer (TNBC) with sacituzumab govitecan... US-10918734-B2 chemical patent summary. triple negative breast cancer https://cordis.europa.eu/project/id/893597/de Tumor compartment-specific effects of P70S6K in early triple negative breast cancer: regulation of... Breast cancer is the most common cancer among women with significant death rates and economic impact. In daily routine clinics, breast cancer is usually... triple negative breast cancer https://eprints.ncl.ac.uk/183762 Triple negative breast cancer: proposals for a pragmatic definition and implications for patient... triple negative breast cancer https://tobias-lib.ub.uni-tuebingen.de/xmlui/handle/10900/141140 De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of... triple negative breast cancer https://www.ucsf.edu/news/2016/10/404701/drug-target-triple-negative-breast-cancer-found-new-study Archive: Drug Target for Triple-Negative Breast Cancer Found in New Study | UC San Francisco A team of researchers led by UCSF scientists has identified a new drug target for triple-negative breast cancer. triple negative breast cancer https://connect.mayoclinic.org/discussion/triple-negative-breast-cancer/ Triple Negative Breast Cancer: What treatments are you having? | Mayo Clinic Connect I have just been diagnosed with Triple Negative Breast Cancer after having Estrogen Positive Breast Cancer for 21 years. Is anyone familiar with this diagnos... triple negative breast cancer https://pubmed.ncbi.nlm.nih.gov/26950360/ Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer Expression of the oncogenic transcription factor MYC is disproportionately elevated in triple-negative breast cancer (TNBC), as compared to estrogen receptor-,... https://www.mdpi.com/2072-6694/15/8/2204 Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative... Breast cancer is a heterogeneous disease with different molecular subtypes. Breast cancer is the second leading cause of mortality in woman due to rapid... treatment for breast cancer recent advances precision medicine https://microbiology.weill.cornell.edu/e3-ubiquitin-ligase-ubr5-drives-growth-and-metastasis-triple-negative-breast-cancer E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer. |... https://pubmed.ncbi.nlm.nih.gov/36612022/?dopt=Abstract On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer ERK3 and ERK4 define a distinct and understudied subfamily of mitogen-activated protein kinases (MAPKs). Little is known about the physiological roles of these... on the therapeutic potential https://pubs.rsc.org/en/Content/ArticleLanding/2026/FO/D5FO05648A Therapeutic effects of selenium-enriched rapeseed against triple-negative breast cancer:... Triple-negative breast cancer (TNBC) presents a major therapeutic challenge due to its aggressive behavior and a microenvironment characterized by a... therapeutic effects selenium enriched https://www.cochrane.org/evidence/CD013750_platinum-containing-regimens-triple-negative-metastatic-breast-cancer Platinum-containing regimens for triple-negative metastatic breast cancer | Cochrane metastatic breast cancer platinum containing regimens triple https://tobias-lib.uni-tuebingen.de/xmlui/handle/10900/52018 19p13.1 Is a Triple-Negative-Specific Breast Cancer Susceptibility Locus is a breast cancer triple https://pubmed.ncbi.nlm.nih.gov/24794243/ Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer... GlaxoSmithKline, Roche, and Teva.

Robuta